Canine Mammary Tumors as a Potential Model for Human Breast Cancer in Comparative Oncology

Clinical and molecular similarities between canine mammary tumors (CMTs) and human breast cancer (HBC) propel scientists to further study their application in comparative oncology as a model for human breast cancer. In total, 64 canine mammary tumors were selected to study the most common markers, w...

Full description

Saved in:
Bibliographic Details
Main Authors: Amirhossein Razavirad, Sanaz Rismanchi, Pejman Mortazavi, Ahad Muhammadnejad
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Veterinary Medicine International
Online Access:http://dx.doi.org/10.1155/2024/9319651
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832553097090564096
author Amirhossein Razavirad
Sanaz Rismanchi
Pejman Mortazavi
Ahad Muhammadnejad
author_facet Amirhossein Razavirad
Sanaz Rismanchi
Pejman Mortazavi
Ahad Muhammadnejad
author_sort Amirhossein Razavirad
collection DOAJ
description Clinical and molecular similarities between canine mammary tumors (CMTs) and human breast cancer (HBC) propel scientists to further study their application in comparative oncology as a model for human breast cancer. In total, 64 canine mammary tumors were selected to study the most common markers, which are applicable for human breast cancer treatment, including estrogen and progesterone receptors (ER and PR), human epidermal growth factor (HER2/neu), Ki67, and cyclooxygenase 2 (Cox2). Immunohistochemistry (IHC) was used to assess the protein expression. The Veterinary Nottingham Prognostic Index (Vet-NPI) was also computed. Moreover, univariate and multivariable Cox proportional hazard analyses were applied to estimate hazard ratios (HRs). The results demonstrated that Ki67 was strongly expressed in the triple-negative tumors, and Ki67 protein expression continuously increased over the increase of Cox2 protein expression (p<0.001). Further analysis revealed a significant difference among canine mammary subtypes and Vet-NPI, in which triple-negative tumors displayed the highest mean score compared to other subtypes (p<0.001). In addition, the multivariable analysis revealed that the regional mastectomy procedure (adjusted HR = 2.78 (1.14–6.8)), the triple-negative tumors (adjusted HR = 48.08 (7.74–298.8)), strong Ki67 protein expression group (adjusted HR = 7.88 (2.02–30.68)), and strong Cox2 protein expression group (adjusted HR = 29.35 (5.18–166.4)) demonstrated significantly lower disease-free survival rates compared to other corresponding groups. Overall, canine mammary tumors showed strong similarities to human breast cancer in terms of clinical and molecular aspects; therefore, they could be suggested as a model for human breast cancer in comparative oncology.
format Article
id doaj-art-ffaf175ba4a4411fbd2961418f223e70
institution Kabale University
issn 2042-0048
language English
publishDate 2024-01-01
publisher Wiley
record_format Article
series Veterinary Medicine International
spelling doaj-art-ffaf175ba4a4411fbd2961418f223e702025-02-03T05:56:55ZengWileyVeterinary Medicine International2042-00482024-01-01202410.1155/2024/9319651Canine Mammary Tumors as a Potential Model for Human Breast Cancer in Comparative OncologyAmirhossein Razavirad0Sanaz Rismanchi1Pejman Mortazavi2Ahad Muhammadnejad3Cancer Biology Research CenterCancer Biology Research CenterDepartment of PathobiologyCancer Biology Research CenterClinical and molecular similarities between canine mammary tumors (CMTs) and human breast cancer (HBC) propel scientists to further study their application in comparative oncology as a model for human breast cancer. In total, 64 canine mammary tumors were selected to study the most common markers, which are applicable for human breast cancer treatment, including estrogen and progesterone receptors (ER and PR), human epidermal growth factor (HER2/neu), Ki67, and cyclooxygenase 2 (Cox2). Immunohistochemistry (IHC) was used to assess the protein expression. The Veterinary Nottingham Prognostic Index (Vet-NPI) was also computed. Moreover, univariate and multivariable Cox proportional hazard analyses were applied to estimate hazard ratios (HRs). The results demonstrated that Ki67 was strongly expressed in the triple-negative tumors, and Ki67 protein expression continuously increased over the increase of Cox2 protein expression (p<0.001). Further analysis revealed a significant difference among canine mammary subtypes and Vet-NPI, in which triple-negative tumors displayed the highest mean score compared to other subtypes (p<0.001). In addition, the multivariable analysis revealed that the regional mastectomy procedure (adjusted HR = 2.78 (1.14–6.8)), the triple-negative tumors (adjusted HR = 48.08 (7.74–298.8)), strong Ki67 protein expression group (adjusted HR = 7.88 (2.02–30.68)), and strong Cox2 protein expression group (adjusted HR = 29.35 (5.18–166.4)) demonstrated significantly lower disease-free survival rates compared to other corresponding groups. Overall, canine mammary tumors showed strong similarities to human breast cancer in terms of clinical and molecular aspects; therefore, they could be suggested as a model for human breast cancer in comparative oncology.http://dx.doi.org/10.1155/2024/9319651
spellingShingle Amirhossein Razavirad
Sanaz Rismanchi
Pejman Mortazavi
Ahad Muhammadnejad
Canine Mammary Tumors as a Potential Model for Human Breast Cancer in Comparative Oncology
Veterinary Medicine International
title Canine Mammary Tumors as a Potential Model for Human Breast Cancer in Comparative Oncology
title_full Canine Mammary Tumors as a Potential Model for Human Breast Cancer in Comparative Oncology
title_fullStr Canine Mammary Tumors as a Potential Model for Human Breast Cancer in Comparative Oncology
title_full_unstemmed Canine Mammary Tumors as a Potential Model for Human Breast Cancer in Comparative Oncology
title_short Canine Mammary Tumors as a Potential Model for Human Breast Cancer in Comparative Oncology
title_sort canine mammary tumors as a potential model for human breast cancer in comparative oncology
url http://dx.doi.org/10.1155/2024/9319651
work_keys_str_mv AT amirhosseinrazavirad caninemammarytumorsasapotentialmodelforhumanbreastcancerincomparativeoncology
AT sanazrismanchi caninemammarytumorsasapotentialmodelforhumanbreastcancerincomparativeoncology
AT pejmanmortazavi caninemammarytumorsasapotentialmodelforhumanbreastcancerincomparativeoncology
AT ahadmuhammadnejad caninemammarytumorsasapotentialmodelforhumanbreastcancerincomparativeoncology